Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Roberto N. Miranda, MD"'
Autor:
Christopher N. Nguyen, BA, Swaminathan P. Iyer, MD, Roberto N. Miranda, MD, Carlos A. Torres-Cabala, MD, Jonathan L. Curry, MD, Penny Fang, MD, Valencia D. Thomas, MD, Auris O. Huen, MD
Publikováno v:
JAAD Case Reports, Vol 17, Iss , Pp 34-37 (2021)
Externí odkaz:
https://doaj.org/article/29f780d90c1a4722916fc4eea6d73f95
Autor:
Carlos Andres Ossa Gomez, MD, MSc, Jose Fernando Robledo Abad, MD, Alejandro Duque, MD, Ramiro Huertas, MD, Ana Maria Fidalgo, MD, Giovanna Rivas Taffur, MD, Jose Joaquin Caicedo Mallarino, MD, Fabio Torres, MD, William Armando Mantilla Duran, MD, Virginia Abello, MD, Roberto N. Miranda, MD, Carolina Echeverri, MD, Mark Warren Clemens, MD, FACS
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 8, Iss 8, p e3013 (2020)
Background:. An estimated 43,390 breast augmentation surgeries (86,780 implants) and 1486 breast implant reconstructions are performed annually in Colombia, representing the second-most breast surgery destination in South America, the fourth in the w
Externí odkaz:
https://doaj.org/article/cce110c8b7a642b2a074993f1f1259f5
Autor:
Summer E. Hanson, MD, PhD, Victor J. Hassid, MD, Cynthia D. Branch-Brooks, Jeffrey Medeiros, MD, Marshall Kadin, MD, Charles Randquist, MD, Roberto N. Miranda, MD, Charles E. Butler, MD, Mark W. Clemens, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 5, Iss 9S, Pp 64-64 (2017)
Externí odkaz:
https://doaj.org/article/c9bd980d33344286b2a75e0f903321df
Autor:
Jaffe ES; Elaine S. Jaffe, MD, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Andrew L. Feldman, MD, Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN; Philippe Gaulard, MD, PhD, Departement de Pathologie, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France; Roberto N. Miranda, MD, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Aliyah R. Sohani, MD, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA., Feldman AL; Elaine S. Jaffe, MD, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Andrew L. Feldman, MD, Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN; Philippe Gaulard, MD, PhD, Departement de Pathologie, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France; Roberto N. Miranda, MD, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Aliyah R. Sohani, MD, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA., Gaulard P; Elaine S. Jaffe, MD, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Andrew L. Feldman, MD, Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN; Philippe Gaulard, MD, PhD, Departement de Pathologie, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France; Roberto N. Miranda, MD, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Aliyah R. Sohani, MD, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA., Miranda RN; Elaine S. Jaffe, MD, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Andrew L. Feldman, MD, Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN; Philippe Gaulard, MD, PhD, Departement de Pathologie, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France; Roberto N. Miranda, MD, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Aliyah R. Sohani, MD, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA., Sohani AR; Elaine S. Jaffe, MD, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Andrew L. Feldman, MD, Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN; Philippe Gaulard, MD, PhD, Departement de Pathologie, Hôpital Henri Mondor, Inserm U955, Université Paris-Est, Créteil, France; Roberto N. Miranda, MD, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Aliyah R. Sohani, MD, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Aug 20; Vol. 38 (24), pp. 2819-2820. Date of Electronic Publication: 2020 Jun 17.